Plasma concentrations of natriuretic peptides in normal cats and normotensive and hypertensive cats with chronic kidney disease

Journal of Veterinary Cardiology

Volumn 11, Issue SUPPL. 1, 2009, Pages

  Lalor, Stephanie M ^a   Connolly, David J ^a   Elliott, Jonathan ^a   Syme, Harriet M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Azotemia; Chronic kidney disease; Hypertension; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; CREATININE;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HYPERTENSION; MALE; NONHUMAN; NONPARAMETRIC TEST; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CAT DISEASES; CATS; CREATININE; FEMALE; HYPERTENSION; KIDNEY DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

ANIMALIA;

EID: 67349234607     PISSN: 17602734     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvc.2009.01.004     Document Type: Article

References (36)

1. Syme H.M., Barber P.J., Markwell P.J., and Elliott J. Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. J Am Vet Med Assoc 220 (2002) 1799-1804
2. Maggio F., DeFrancesco T.C., Atkins C.E., Pizzirani S., Gilger B.C., and Davidson M.G. Ocular lesions associated with systemic hypertension in cats: 69 cases (1985-1998). J Am Vet Med Assoc 217 (2000) 695-702
3. Snyder P.S., Sadek D., and Jones G.L. Effect of amlodipine on echocardiographic variables in cats with systemic hypertension. J Vet Intern Med 15 (2001) 52-56
4. Chetboul V., Lefebvre H.P., Pinhas C., Clerc B., Boussouf M., and Pouchelon J.L. Spontaneous feline hypertension: clinical and echocardiographic abnormalities, and survival rate. J Vet Intern Med 17 (2003) 89-95
5. Henik R.A., Stepien R.L., and Bortnowski H.B. Spectrum of M-mode echocardiographic abnormalities in 75 cats with systemic hypertension. J Am Anim Hosp Assoc 40 (2004) 359-363
6. Carlos Sampedrano C., Chetboul V., Gouni V., Nicolle A.P., Pouchelon J.L., and Tissier R. Systolic and diastolic myocardial dysfunction in cats with hypertrophic cardiomyopathy or systemic hypertension. J Vet Intern Med 20 (2006) 1106-1115
7. Pedersen F., Raymond I., Kistorp C., Sandgaard N., Jacobsen P., and Hildebrandt P. N-terminal pro-brain natriuretic peptide in arterial hypertension: a valuable prognostic marker of cardiovascular events. J Card Fail 11 (2005) S70-S75
8. Morillas P., Castillo J., Quiles J., Nunez D., Guillen S., Maceira A., Rivera M., and Bertomeu V. Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study. Rev Esp Cardiol 61 (2008) 972-975
9. Spranger C.B., Ries A.J., Berge C.A., Radford N.B., and Victor R.G. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med 117 (2004) 14-18
10. Cuspidi C., Meani S., Valerio C., Fusi V., Sala C., and Zanchetti A. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives. J Hypertens 24 (2006) 1671-1677
11. Mukoyama M., Nakao K., Saito Y., Ogawa Y., Hosoda K., Suga S., Shirakami G., Jougasaki M., and Imura H. Human brain natriuretic peptide, a novel cardiac hormone. Lancet 335 (1990) 801-802
12. Kohno M., Horio T., Yokokawa K., Murakawa K., Yasunari K., Akioka K., Tahara A., Toda I., Takeuchi K., Kurihara N., et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 92 (1992) 29-34
13. Olsen M.H., Hansen T.W., Christensen M.K., Gustafsson F., Rasmussen S., Wachtell K., Borch-Johnsen K., Ibsen H., Jorgensen T., and Hildebrandt P. N-terminal pro-brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46 (2005) 660-666
14. Shikata C., Sekikawa T., Kimura N., Kojima A., Seki S., Oka H., Nishiyama A., and Takeda N. Beneficial effect of combination therapy with antihypertensive drugs in patients with hypertension. Exp Clin Cardiol 12 (2007) 33-36
15. Hildebrandt P., and Richards A.M. Amino-terminal pro-B-type natriuretic peptide testing in patients with diabetes mellitus and with systemic hypertension. Am J Cardiol 101 (2008) 21-24
16. Ceyhan C., Unal S., Yenisey C., Tekten T., and Ceyhan F.B. The role of N-terminal pro-brain natriuretic peptide in the evaluation of left ventricular diastolic dysfunction: correlation with echocardiographic indexes in hypertensive patients. Int J Cardiovasc Imaging 24 (2008) 253-259
17. London G.M., Safar M.E., Safar A.L., and Simon A.C. Blood pressure in the 'low-pressure system' and cardiac performance in essential hypertension. J Hypertens 3 (1985) 337-342
18. Nishikimi T., Yoshihara F., Morimoto A., Ishikawa K., Ishimitsu T., Saito Y., Kangawa K., Matsuo H., Omae T., and Matsuoka H. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28 (1996) 22-30
19. Connolly D.J., Magalhaes R.J., Syme H.M., Boswood A., Fuentes V.L., Chu L., and Metcalf M. Circulating natriuretic peptides in cats with heart disease. J Vet Intern Med 22 (2008) 96-105
20. MacLean H.N., Abbott J.A., Ward D.L., Huckle W.R., Sisson D.D., and Pyle R.L. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy. J Vet Intern Med 20 (2006) 284-289
21. Charles C.J., Espiner E.A., Nicholls M.G., Richards A.M., Yandle T.G., Protter A., and Kosoglou T. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep. Am J Physiol Regul Integr Comp Physiol 271 (1996) R373-R380
22. Goetze J.P., Jensen G., Møller S., Bendtsen F., Rehfeld J.F., and Henriksen J.H. BNP and N-terminal proBNP are both extracted in the normal kidney. Eur J Clin Invest 36 (2006) 8-15
23. Boswood A., Dukes-McEwan J., Loureiro J., James R.A., Martin M., Stafford-Johnson M., Smith P., Little C., and Attree S. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. J Small Anim Pract 49 (2008) 26-32
24. Mark P.B., Stewart G.A., Gansevoort R.T., Petrie C.J., McDonagh T.A., Dargie H.J., Rodger R.S., and Jardine A.G. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Transplant 21 (2006) 402-410
25. Jepson R.E., Elliott J., Brodbelt D., and Syme H.M. Effect of control of systolic blood pressure on survival in cats with systemic hypertension. J Vet Intern Med 21 (2007) 402-409
26. Januzzi J.J.L., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A., Krauser D.G., Tung R., Cameron R., Nagurney J.T., Chae C.U., Lloyd-Jones D.M., Brown D.F., Foran-Melanson S., Sluss P.M., Lee-Lewandrowski E., and Lewandrowski K.B. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
27. Belew A.M., Barlett T., and Brown S.A. Evaluation of the white-coat effect in cats. J Vet Intern Med 13 (1999) 134-142
28. Wong T.Y., and McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 73-74 (2005) 57-70
29. Apple F.S., Murakami M.M., Pearce L.A., and Herzog C.A. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 50 (2004) 2279-2285
30. Das S.R., Abdullah S.M., Leonard D., Drazner M.H., Khera A., McGuire D.K., and de Lemos J.A. Association between renal function and circulating levels of natriuretic peptides (from the Dallas heart study). Am J Cardiol 102 (2008) 1394-1398
31. Bruch C., Fischer C., Sindermann J., Stypmann J., Breithardt G., and Gradaus R. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease. Am J Cardiol 102 (2008) 469-474
32. Cauliez B., Guignery J., Marinier S., Mariau I., and Lavoinne A. Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system. Ann Clin Biochem 45 (2008) 318-319
33. Buckley M.G., Marcus N.J., and Yacoub M.H. Cardiac peptide stability, aprotinin and room temperature: importance for assessing cardiac function in clinical practice. Clin Sci 97 (1999) 689-695
34. Raymond I., Groenning B.A., Hildebrandt P.R., Nilsson J.C., Baumann M., Trawinski J., and Pedersen F. The influence of age, sex and other variables on the plasma level of N-terminal pro-brain natriuretic peptide in a large sample of the general population. Heart 89 (2003) 745-751
35. Connolly D.J., Soares Magalhaes R.J., Luis Fuentes V., Syme H.M., Cole G., and Boag A.M. Circulating natriuretic peptide concentrations in cats with respiratory distress [abstract]. J Vet Intern Med 22 (2008) 719-720
36. Fox P.R., Oyama M.A., MacDonald K., and Reynold C.A. Comparison of NT-proBNP concentration in cats with acute dyspnea from cardiac or respiratory disease [abstract]. J Vet Intern Med 22 (2008) 719